Perry J. Sternberg

Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.

Part of Amplifon SpA, Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ is an American company that manufactures and markets hearing aids and related products. Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business was acquired by Amplifon SpA from Bausch & Lomb, Inc. on August 30, 1999.

Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA.

Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023.

Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers.